TY - JOUR
T1 - New understanding and treatment of diabetic neuropathy
AU - Dyck, Peter James
PY - 1992/5/7
Y1 - 1992/5/7
N2 - IN this issue of the Journal, two specific problems in diabetic neuropathy are addressed. Said and coworkers describe the pathologic changes in sural-nerve biopsy specimens in five atypical cases of diabetic polyneuropathy.1 They find evidence in these cases of a dying-back neuropathy affecting the longest axons. Max and coworkers2 assess the relative efficacy of desipramine, amitriptyline, and fluoxetine in controlling pain in diabetic neuropathy. These articles reflect the increasing attention being given to diabetic neuropathy. This increased interest focuses on estimating the frequency, severity, and natural history of diabetic neuropathies; on their causes; on treatments that prevent or ameliorate.
AB - IN this issue of the Journal, two specific problems in diabetic neuropathy are addressed. Said and coworkers describe the pathologic changes in sural-nerve biopsy specimens in five atypical cases of diabetic polyneuropathy.1 They find evidence in these cases of a dying-back neuropathy affecting the longest axons. Max and coworkers2 assess the relative efficacy of desipramine, amitriptyline, and fluoxetine in controlling pain in diabetic neuropathy. These articles reflect the increasing attention being given to diabetic neuropathy. This increased interest focuses on estimating the frequency, severity, and natural history of diabetic neuropathies; on their causes; on treatments that prevent or ameliorate.
UR - http://www.scopus.com/inward/record.url?scp=0026549724&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026549724&partnerID=8YFLogxK
U2 - 10.1056/NEJM199205073261910
DO - 10.1056/NEJM199205073261910
M3 - Editorial
C2 - 1560806
AN - SCOPUS:0026549724
SN - 0028-4793
VL - 326
SP - 1287
EP - 1288
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 19
ER -